The antihyperlipidemic effects of fullerenol nanoparticles via adjusting the gut microbiota in vivo

Abstract

Nanoparticles (NPs) administered orally will meet the gut microbiota, but their impacts on microbiota homeostasis and the consequent physiological relevance remain largely unknown. Here, we describe the modulatory effects and the consequent pharmacological outputs of two orally administered fullerenols NPs (Fol1 C60(OH)7(O)8 and Fol113 C60(OH)11(O)6) on gut… (More)
DOI: 10.1186/s12989-018-0241-9

8 Figures and Tables

Topics

  • Presentations referencing similar topics